Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7295 USD | -4,01% | +16,29% | -47,89% |
Omzet 2024 * | 1,16 mln. 1,09 mln. | Omzet 2025 * | 7,64 mln. 7,12 mln. | Marktkapitalisatie | 110 mln. 103 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -186 mln. -173 mln. | Nettowinst (verlies) 2025 * | -153 mln. -143 mln. | EV/omzet 2024 * | 238 x |
Nettoschuld 2024 * | 167 mln. 155 mln. | Nettoschuld 2025 * | 243 mln. 227 mln. | EV/omzet 2025 * | 46,2 x |
K/w-verhouding 2024 * |
-0,64
x | K/w-verhouding 2025 * |
-0,91
x | Werknemers | 233 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,29% |
Recentste transcriptie over Seres Therapeutics, Inc.
1 dag | -4,01% | ||
1 week | +16,29% | ||
Lopende maand | -5,76% | ||
1 maand | -5,11% | ||
3 maanden | -36,57% | ||
6 maanden | -52,48% | ||
Lopend jaar | -47,89% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 01-11-14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-10-20 |
Chief Tech/Sci/R&D Officer | - | 01-05-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 01-04-15 |
Director/Board Member | 68 | 04-01-23 | |
Richard Kender
BRD | Director/Board Member | 68 | 06-10-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.06% | 0 M€ | 0,00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0,00% | - | |
0.03% | 237 M€ | +1,49% | - | |
0.02% | 7 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 0,7295 | -4,01% | 5 812 246 |
23-04-24 | 0,76 | +21,68% | 11 876 377 |
22-04-24 | 0,6246 | +11,56% | 4 223 862 |
19-04-24 | 0,5599 | -4,16% | 3 748 612 |
18-04-24 | 0,5842 | -6,87% | 3 788 552 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-47,89% | 110 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,78% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,14% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |